Guangzhou Pharmaceuticals

Wanglaoji Accelerates International Market Expansion by Launching the International Brand Identity WALOVI in Thailand

Retrieved on: 
Saturday, March 30, 2024
Health, Guangzhou Pharmaceuticals, Party, Multimedia, Herbal, Tea

GUANGZHOU, China, March 30, 2024 /PRNewswire/ -- On March 30, in Bangkok, Thailand, Guangzhou Pharmaceutical Holdings Limited (GPHL) held a ceremony for signing up Wanglaoji (Bangkok) Herbal Tea Museum and launching Wanglaoji international brand identity (Bangkok).

Key Points: 
  • GUANGZHOU, China, March 30, 2024 /PRNewswire/ -- On March 30, in Bangkok, Thailand, Guangzhou Pharmaceutical Holdings Limited (GPHL) held a ceremony for signing up Wanglaoji (Bangkok) Herbal Tea Museum and launching Wanglaoji international brand identity (Bangkok).
  • This event aims at being based on Thailand, radiating to Southeast Asia, promoting further internationalization of Wanglaoji herbal tea.
  • 1 natural plant drink brand in the world, Wanglaoji launched the international brand identity WALOVI to accelerate its pace of internationalization.
  • The Southeast Asian market is a key overseas sales market for Wanglaoji.

Wanglaoji Accelerates International Market Expansion by Launching the International Brand Identity WALOVI in Thailand

Retrieved on: 
Saturday, March 30, 2024
Health, Guangzhou Pharmaceuticals, Party, Herbal, Tea

GUANGZHOU, China, March 30, 2024 /PRNewswire/ -- On March 30, in Bangkok, Thailand, Guangzhou Pharmaceutical Holdings Limited (GPHL) held a ceremony for signing up Wanglaoji (Bangkok) Herbal Tea Museum and launching Wanglaoji international brand identity (Bangkok).

Key Points: 
  • GUANGZHOU, China, March 30, 2024 /PRNewswire/ -- On March 30, in Bangkok, Thailand, Guangzhou Pharmaceutical Holdings Limited (GPHL) held a ceremony for signing up Wanglaoji (Bangkok) Herbal Tea Museum and launching Wanglaoji international brand identity (Bangkok).
  • This event aims at being based on Thailand, radiating to Southeast Asia, promoting further internationalization of Wanglaoji herbal tea.
  • 1 natural plant drink brand in the world, Wanglaoji launched the international brand identity WALOVI to accelerate its pace of internationalization.
  • Among them, the Thailand market is highly recognized for outstanding performance and is expected to maintain rapid development momentum this year.

Overseas Brand WALOVI of Wanglaoji Made Its Debut Globally to Share the Eastern Health Philosophy with the World

Retrieved on: 
Thursday, February 29, 2024
Society, Traditional Chinese medicine, Conference, Health, SGS, Costco, International standard, Guangzhou Pharmaceuticals, World government, Amazon, Party, Research, Tourism

GUANGZHOU, China, Feb. 29, 2024 /PRNewswire/ -- Wanglaoji unveiled its international overseas brand "WALOVI" globally at the 2024 Milan-Guangzhou Business Environment Promotion Conference and China-Italy Economic and Trade Cooperation and Exchange Meeting on February 26th.

Key Points: 
  • GUANGZHOU, China, Feb. 29, 2024 /PRNewswire/ -- Wanglaoji unveiled its international overseas brand "WALOVI" globally at the 2024 Milan-Guangzhou Business Environment Promotion Conference and China-Italy Economic and Trade Cooperation and Exchange Meeting on February 26th.
  • Wanglaoji introduced its international overseas brand to overseas markets, and established the first European herbal tea museum, aiming to win over global consumers with this natural plant-based drink from China, and to share the eastern health philosophy with the world.
  • Currently, Wanglaoji has entered overseas platforms such as Yamibuy, Amazon and Costco.
  • Today, Wanglaoji's sales network covers 150 countries and regions on five continents, including dozens of countries in Europe.

Overseas Brand WALOVI of Wanglaoji Made Its Debut Globally to Share the Eastern Health Philosophy with the World

Retrieved on: 
Thursday, February 29, 2024
Society, Multimedia, Traditional Chinese medicine, Conference, Health, SGS, Costco, International standard, Guangzhou Pharmaceuticals, World government, Amazon, Party, Research, Tourism

GUANGZHOU, China, Feb. 29, 2024 /PRNewswire/ -- Wanglaoji unveiled its international overseas brand "WALOVI" globally at the 2024 Milan-Guangzhou Business Environment Promotion Conference and China-Italy Economic and Trade Cooperation and Exchange Meeting on February 26th.

Key Points: 
  • GUANGZHOU, China, Feb. 29, 2024 /PRNewswire/ -- Wanglaoji unveiled its international overseas brand "WALOVI" globally at the 2024 Milan-Guangzhou Business Environment Promotion Conference and China-Italy Economic and Trade Cooperation and Exchange Meeting on February 26th.
  • Wanglaoji introduced its international overseas brand to overseas markets, and established the first European herbal tea museum, aiming to win over global consumers with this natural plant-based drink from China, and to share the eastern health philosophy with the world.
  • Currently, Wanglaoji has entered overseas platforms such as Yamibuy, Amazon and Costco.
  • Today, Wanglaoji's sales network covers 150 countries and regions on five continents, including dozens of countries in Europe.

Trademark WALOVI Made Its Debut Globally to Share the Chinese Herbal Tea Culture with the World

Retrieved on: 
Tuesday, February 27, 2024
Well, Culture, Belt, Conference, Auspicious, Guangzhou Pharmaceuticals, Tea

The theme of the event was "Bringing Good Fortune to the World: A Well-established Traditional Chinese Brand Introduces Ji (Auspicious) Culture to the World".

Key Points: 
  • The theme of the event was "Bringing Good Fortune to the World: A Well-established Traditional Chinese Brand Introduces Ji (Auspicious) Culture to the World".
  • With the mission of "bringing good fortune to the world", Wanglaoji introduced its international trademark to overseas markets and established the first European herbal tea museum, aiming to win over global consumers with this healthy natural herbal drink from China.
  • By doing that, we can transform from a national brand to an international one and thus continue to carry forward the exchanges between the herbal tea industry and the world, share Chinese herbal tea culture globally, and spearhead the trend of consuming healthy plant-based beverages."
  • Looking forward, Wanglaoji will adhere to the mission of "bringing good fortune to the world" and further promote scientific and technological innovation and development for the health industry, thus making Chinese herbal tea the world's herbal tea.

Trademark WALOVI Made Its Debut Globally to Share the Chinese Herbal Tea Culture with the World

Retrieved on: 
Tuesday, February 27, 2024
Well, Culture, Belt, Conference, Auspicious, Guangzhou Pharmaceuticals, Tea

The theme of the event was "Bringing Good Fortune to the World: A Well-established Traditional Chinese Brand Introduces Ji (Auspicious) Culture to the World".

Key Points: 
  • The theme of the event was "Bringing Good Fortune to the World: A Well-established Traditional Chinese Brand Introduces Ji (Auspicious) Culture to the World".
  • With the mission of "bringing good fortune to the world", Wanglaoji introduced its international trademark to overseas markets and established the first European herbal tea museum, aiming to win over global consumers with this healthy natural herbal drink from China.
  • By doing that, we can transform from a national brand to an international one and thus continue to carry forward the exchanges between the herbal tea industry and the world, share Chinese herbal tea culture globally, and spearhead the trend of consuming healthy plant-based beverages."
  • Looking forward, Wanglaoji will adhere to the mission of "bringing good fortune to the world" and further promote scientific and technological innovation and development for the health industry, thus making Chinese herbal tea the world's herbal tea.

Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture

Retrieved on: 
Monday, November 2, 2020
Discount, Variety, Seniors, Supermarket, Specialty, Convenience store, General Health, Pharmaceutical, Consumer, Health, Retail, Companies, McKesson Europe, Pharmacy, Health care, Walgreens, McKesson Corporation, Ornella Barra, Alliance Healthcare, Boots, MCK, WBA, Guangzhou Pharmaceuticals, Walgreens Boots Alliance, McKesson

Walgreens Boots Alliance (Nasdaq: WBA) and McKesson Corporation (NYSE: MCK) today announced the completion of their previously announced agreement to create a joint venture combining their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE).

Key Points: 
  • Walgreens Boots Alliance (Nasdaq: WBA) and McKesson Corporation (NYSE: MCK) today announced the completion of their previously announced agreement to create a joint venture combining their respective pharmaceutical wholesale businesses in Germany, Alliance Healthcare Deutschland (AHD) and GEHE Pharma Handel (GEHE).
  • WBA holds a 70 percent controlling equity interest in the joint venture and McKesson holds the remaining 30 percent interest.
  • At Walgreens Boots Alliance, we all look forward to working together with McKesson Corporation on this joint venture, said Ornella Barra, co-chief operating officer, Walgreens Boots Alliance.
  • The completion of this strategic partnership with Walgreens Boots Alliance enables us to strengthen and secure the future of pharmaceutical distribution in the German market, said Kevin Kettler, chairman of the management board and president McKesson International.

111, Inc. Partners with Baiyunshan Pharmaceutical Sales in Digital Medicine Innovation

Retrieved on: 
Friday, September 4, 2020
Pharmaceutical industry in China, Pharmaceuticals policy, Pharmacy in China, Science and technology in the People's Republic of China, Guangzhou Pharmaceuticals, Health

Under the agreement, 111 will be the first Internet-based omni-channel business partner of Baiyunshan Pharmaceutical Sales.

Key Points: 
  • Under the agreement, 111 will be the first Internet-based omni-channel business partner of Baiyunshan Pharmaceutical Sales.
  • Pei Zejian, Vice Director, Great South TCM, Guangzhou Pharmaceutical Holdings Limited, Secretary of the Party Committee and Chairman of Guangzhou Baiyunshan Pharmaceutical Sales Co., Ltd., said the pandemic further accelerated the development of digital healthcare industry and Internet is becoming an increasingly important channel to pharmaceutical companies.
  • Driven by 111's digital technology, and supported by the strategy of omni-channel drug commercialization and online/offline integration, the high-quality products of Baiyunshan Pharmaceutical Sales can reach more customers.
  • AboutGuangzhou Baiyunshan Pharmaceutical Sales Co., Ltd andCompany
    Baiyunshan Pharmaceutical Sales Co., Ltd. is an all-in-one marketing platform of Guangzhou Pharmaceuticals Corporation, which has so far integrated marketing businesses of four companies, namely, Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., Guangzhou Baiyunshan Guanghua Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co., Ltd. and Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.

China Pharmaceutical Distribution Industry Report to 2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 28, 2020
Health, Pharmaceutical, Health, Economy of China, Pharmaceutical industry in China, Pharmaceuticals policy, Pharmacy in China, Science and technology in the People's Republic of China, Huadong Medicine, Guangzhou Pharmaceuticals, Pharmaceutical industry, China National Pharmaceutical Group, Simcere Pharmaceutical

The "China Pharmaceutical Distribution Industry Report, 2019-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Pharmaceutical Distribution Industry Report, 2019-2026" report has been added to ResearchAndMarkets.com's offering.
  • Western medicine sales dominate pharmaceutical distribution in China, accounting for 72.2% in 2018 the sales in East China and Central South China seize larger shares up to 62.1% together in 2018.
  • A competition pattern has been developed in the country where there are national pharmaceutical distributors represented by China National Pharmaceutical Group Corporation (Sinopharm), China Resources Pharmaceutical Commercial Group, Shanghai Pharmaceuticals and Jointown Pharmaceutical Group and the regional ones represented by NanJing Pharmaceutical, Guangzhou Pharmaceuticals, Chongqing Pharmaceutical, Huadong Medicine, Sichuan Kelun, Zhejiang Int'l, Realcan Pharmaceutical, Guangxi Liuzhou Pharmaceutical Co., Ltd. and Luyan Pharma Co., Ltd.
  • Pharmaceutical distribution industry in China (development environment, status quo, market size/structure, competitive landscape, development trends, etc.)

China Pharmaceutical Distribution Industry Report, 2019-2026

Retrieved on: 
Monday, May 4, 2020
Health, Pharmaceutical industry in China, Pharmaceuticals policy, Pharmacy in China, Science and technology in the People's Republic of China, Huadong Medicine, Guangzhou Pharmaceuticals, Pharmaceutical industry in India, Pharmaceutical companies, Taiho Pharmaceutical

Western medicine sales dominate pharmaceutical distribution in China, accounting for 72.2% in 2018; the sales in East China and Central South China seize larger shares up to 62.1% together in 2018.

Key Points: 
  • Western medicine sales dominate pharmaceutical distribution in China, accounting for 72.2% in 2018; the sales in East China and Central South China seize larger shares up to 62.1% together in 2018.
  • A competition pattern has been developed in the country where there are national pharmaceutical distributors represented by China National Pharmaceutical Group Corporation (Sinopharm), China Resources Pharmaceutical Commercial Group, Shanghai Pharmaceuticals and Jointown Pharmaceutical Group and the regional ones represented by NanJing Pharmaceutical, Guangzhou Pharmaceuticals, Chongqing Pharmaceutical, Huadong Medicine, Sichuan Kelun, Zhejiang Int'l, Realcan Pharmaceutical, Guangxi Liuzhou Pharmaceutical Co., Ltd. and Luyan Pharma Co., Ltd.
    As of end of November 2018, there had been 13,598 pharmaceutical wholesalers nationwide which competed fiercely in the scattered market.
  • Huge potentials of the pharmaceutical distribution industry has lured investors and frequent M&As occurred over the recent years.
  • Pharmaceutical distribution industry in China (development environment, status quo, market size/structure, competitive landscape, development trends, etc.